张铮,高磊,曹丰

• 1:中国人民解放军总医院心血管内科
• 2:火箭军总医院心血管内科

摘要(Abstract)：

<正>从经皮穿刺冠状动脉腔内成形术(percutaneous transluminal coronary angioplasty,PTCA)到裸金属支架(bare metal stenting,BMS),再到药物洗脱支架(drug eluting stent,DES),经皮冠状动脉介入治疗(percutaneous cor?onary intervention,PCI)经历了重大的发展,但支架内再狭窄(in stent restenosis,ISR)仍然是临床实践中具有挑战性的关键问题。光学相干断层成像(optical coherence tomography,OCT)是一种新型的成像工具,具有极高的轴向

关键词(KeyWords)： 药物洗脱支架;光学相干断层成像;支架内再狭窄

Abstract:

Keywords:

基金项目(Foundation): 国家自然科学基金青年项目(81400274);国家自然科学基金面上项目(81671731);; 首都临床特色应用研究(Z171100001017158)

作者(Author): 张铮,高磊,曹丰

参考文献(References)：

• [1]Cassese S,Byrne RA,Tada T,et al.Incidence and predictors of restenosis after coronary stenting in 10 004 patients with surveillance angiography.Heart,2014,100(2):153-159.
• [2]Siontis GC,Stefanini GG,Mavridis D,et al.Percutaneous coronary interventional strategies for treatment of in stent restenosis:a network meta analysis.Lancet,2015,386(9994):655-664.
• [3]Kawasaki M,Bouma BE,Bressner J,et al.Diagnostic accuracy of optical coherence tomography and integrated backscatter intravascular ultrasound images for tissue characterization of human coronary plaques.J Am Coll Cardiol,2006,48(1):81-88.
• [4]Patwari P,Weissman NJ,Boppart SA,et al.Assessment of coronary plaque with optical coherence tomography and high frequency ultrasound.Am J Cardiol,2000,85(5):641-644.
• [5]Yabushita H,Bouma BE,Houser SL,et al.Characterization of human atherosclerosis by optical coherence tomography.Circulation,2002,106(13):1640-1645.
• [6]Gonzalo N,Serruys PW,Okamura T,et al.Optical coherence tomography patterns of stent restenosis.Am Heart J,2009,158(2):284-293.
• [7]Habara M,Terashima M,Nasu K,et al.Morphological differences of tissue characteristics between early,late,and very late restenosis lesions af ter f irst generation drug eluting stent implantation:an optical coherence tomography study.Eur Heart J Cardiovasc Imaging,2013,14(3):276-284.
• [8]Lee SJ,Kim BK,Kim JS,et al.Evaluation of neointimal morphology of lesions with or without in stent restenosis:an optical coherence tomography study.Clin Cardiol,2011,34(10):633-639.
• [9]Tada T,Kadota K,Hosogi S,et al.Association between tissue characteristics assessed with optical coherence tomography and mid term results after percutaneous coronary intervention for in stent restenosis lesions:a comparison between balloon angioplasty,paclitaxel coated balloon dilatation,and drug eluting stent implantation.Eur Heart J Cardiovasc Imaging,2015,16(10):1101-1111.
• [10]Nagai H,Ishibashi Ueda H,Fujii K.Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus eluting stent restenosis.Catheter Cardiovasc Interv,2010,75(6):961-963.
• [11]Habara M,Terashima M,Nasu K,et al.Difference of tissue characteristics between early and very late restenosis lesions after bare metal stent implantation:an optical coherence tomography study.Circ Cardiovasc Interv,2011,4(3):232-238.
• [12]Teramoto T,Ikeno F,Otake H,et al.Intriguing peri strut low intensity area detected by optical coherence tomography af ter coronary stent deployment.Circ J,2010,74(6):1257-1259.
• [13]Otake H,Shite J,Ikeno F,et al.Evaluation of the peri strut low intensity area following sirolimus-and paclitaxel eluting stents implantation:insights from an optical coherence tomography study in humans.Int J Cardiol,2012,157(1):38-42.
• [14]Nakano M,Vorpahl M,Otsuka F,et al.Ex vivo assessment of vascular response to coronary stents by optical frequency domain imaging.JACC Cardiovasc Imaging,2012,5(1):71-82.
• [15]Lutter C,Mori H,Yahagi K,et al.Histopathological differential diagnosis of optical coherence tomography image interpretation after stenting.JACC Cardiovasc Interv,2016,9(24):2511-2523.
• [16]Joner M,Giacoppo D,Kastrati A.Molecular multimodality imaging:has a long standing dream come true?Eur Heart J,2016,38:456-458.
• [17]Hara T,Ughi GJ,Mccarthy JR,et al.Intravascular fi brin molecular imaging improves the detection of unhealed stents assessed by optical coherence tomography in vivo.Eur Heart J,2017,38(6):447-455.
• [18]Byrne RA,Joner M,Kastrati A.Stent thrombosis and restenosis:what have we learned and where are we going?The Andreas Grüntzig Lecture ESC 2014.Eur Heart J,2015,36(47):3320-3331.
• [19]Farb A,Kolodgie FD,Hwang JY,et al.Extracellular matrix changes in stented human coronary arteries.Circulation,2004,110(8):940-947.
• [20]Jinnouchi H,Kuramitsu S,Shinozaki T,et al.Difference of tissue characteristics between early and late restenosis after second generation drug eluting stents implantation-an Optical Coherence Tomography study.Circ J,2017,81(4):450-457
• [21]Otsuka F,Byrne RA,Yahagi K,et al.Neoatherosclerosis:overview of histopathologic findings and implications for intravascular imaging assessment.Eur Heart J,2015,36(32):2147-2159.
• [22]Kim JS,Lee JH,Shin DH,et al.Long term outcomes of neointimal hyperplasia without neoatherosclerosis af ter drug eluting stent implantation.JACC Cardiovasc Imaging,2014,7(8):788-795.
• [23]Kim JS,Afari ME,Ha J,et al.Neointimal patterns obtained by optical coherence tomography correlate with specific histological components and neointimal proliferation in a swine model of restenosis.Eur Heart J Cardiovasc Imaging,2014,15(3):292-298.
• [24]Fleg JL,Stone GW,Fayad ZA,et al.Detection of high risk athero sclerotic plaque:report of the NHLBI Working Group on current status and future directions.JACC Cardiovasc Imaging,2012,5(9):941-955.
• [25]Yun KH,Mintz GS,Farhat N,et al.Relation between angiographic lesion severity,vulnerable plaque morphology and future adverse cardiac events(from the Providing Regional Observa-tions to Study Predictors of Events in the Coronary Tree study).Am J Cardiol,2012,110(4):471-477.
• [26]Alfonso F,Pérez-Vizcayno MJ,Cárdenas A,et al.A prospective randomized trial of drug eluting balloons versus everolimus eluting stents in patients with in stent restenosis of drug eluting stents:the RIBS IV randomized clinical trial.J Am Coll Cardiol,2015,66(1):23-33.
• [27]Byrne RA,Neumann FJ,Mehilli J,et al.Paclitaxel eluting balloons,paclitaxel eluting stents,and balloon angioplasty in patients with restenosis after implantation of a drug eluting stent(ISAR DESIRE 3):a randomised,open label trial.Lancet,2013,381(9856):461-467.
• [28]Lee JM,Park J,Kang J,et al.Comparison among drug eluting balloon,drug eluting stent,and plain balloon angioplasty for the treatment of in stent restenosis:a network meta analysis of 11randomized,controlled trials.JACC Cardiovasc Interv,2015,8(3):382-394.